In this episode, I dive into the recent developments in the psychedelic world, exploring the FDA advisory panel's surprising vote against the use of MDMA for treating PTSD. Join us as I unpack the implications of this decision and reflect on what it means for the future of psychedelic therapy. To put it in context, I provide a little historical back story on how MDMA became a Schedule I drug. I then discuss the history of MAPS and their tireless work to bring MDMA back into the therapeutic world as a legal medicine. I talk about the wisdom of the medicine, lessons on integrity, ethical standards, and the importance of accountability in psychedelic therapy. Finally, I explore the difference between intention and expectation in psychedelic experiences and how the medicine can often say no to us when we show up with an expectation instead of an open-minded intention. Until next time, keep exploring and growing together!   RECEIVE YOUR FREE GUIDE: "PSYCHEDELIC SAFETY TIPS INCLUDING WHAT TO DO WHEN THINGS GO WRONG:  https://psychedelicdivas.com/

Ver todos los episodios